Have you evaluated the performance of Exelixis' (EXEL) international operations during the quarter that concluded in March 2025? Considering the extensive worldwide presence of this drug developer, analyzing the patterns in international revenues is crucial for understanding its financial resilience and potential for growth. The global economy today is deeply interlinked, making a company's engagement with international markets a critical factor in determining its financial success and growth path. It has b ...